Literature DB >> 26457068

Ideal sphere-forming culture conditions to maintain pluripotency in a hepatocellular carcinoma cell lines.

Seon Ok Min1, Sang Woo Lee1, Seon Young Bak1, Kyung Sik Kim2.   

Abstract

BACKGROUND: Cancer stem cells (CSCs) constitute 1-2 % of cancer tissue and are a major cause of tumor metastasis and recurrence. The culture environment is important in maintaining CSCs in vitro. Sphere formation is one method of culturing CSCs. In this study, we identified and validated optimal culture conditions for sphere formation in hepatocellular carcinoma cells.
METHODS: Huh7 and HepG2 cells were plated in three different media types and were allowed to form spheres. To confirm the pluripotency of sphere cells, the expression of stem cell markers was evaluated. EpCAM, Connexin 32, and Connexin 43 expression was evaluated using reverse transcription-polymerase chain reaction (RT-PCR). The expression of E-cadherin, β-catenin, CD90, and CD133 was evaluated using immunocytochemistry. Flow cytometry was performed to confirm the presence of stem cell markers CD133 and Connexin 32.
RESULTS: Cells maintained in medium containing growth factors ((DMEM(+))GF) showed greater cell proliferation than cells in media with fetal bovine serum (FBS) (DMEM(+)FBS) or without FBS (DMEM(-)FBS). Cells cultured in DMEM(+)FBS medium exhibited greater proliferation after 20 days in culture than cells cultured under the other two conditions. Cells cultured in DMEM(-)FBS medium did not proliferate; therefore, this condition was removed from further analysis. RT-PCR and flow cytometry showed that sphere-forming cells cultured in DMEM(+)GF and DMEM(+)FBS media had similar expression of stem cell markers.
CONCLUSION: Therefore, growth factor-free medium is an adaptable, efficient, and cost-effective tool for in vitro cultivation of CSCs.

Entities:  

Keywords:  Bovine serum albumin; Hep G2 cells; Neoplastic stem cells; Pluripotent stem cells

Year:  2015        PMID: 26457068      PMCID: PMC4599746          DOI: 10.1186/s12935-015-0240-y

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  21 in total

Review 1.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

2.  Establishment of clonal colony-forming assay system for pancreatic stem/progenitor cells.

Authors:  Atsushi Suzuki; Kazunobu Oyama; Katashi Fukao; Hiromitsu Nakauchi; Hideki Taniguchi
Journal:  Cell Transplant       Date:  2002       Impact factor: 4.064

Review 3.  Anchorage dependence, integrins, and apoptosis.

Authors:  E Ruoslahti; J C Reed
Journal:  Cell       Date:  1994-05-20       Impact factor: 41.582

4.  Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells.

Authors:  Atsushi Suetsugu; Masahito Nagaki; Hitomi Aoki; Tsutomu Motohashi; Takahiro Kunisada; Hisataka Moriwaki
Journal:  Biochem Biophys Res Commun       Date:  2006-11-02       Impact factor: 3.575

5.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Authors:  Stephanie Ma; Kwok-Wah Chan; Liang Hu; Terence Kin-Wah Lee; Jana Yim-Hung Wo; Irene Oi-Lin Ng; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Gastroenterology       Date:  2007-04-15       Impact factor: 22.682

6.  Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.

Authors:  Zheng Zhu; Xiangfang Hao; Mingxia Yan; Ming Yao; Chao Ge; Jianren Gu; Jinjun Li
Journal:  Int J Cancer       Date:  2010-05-01       Impact factor: 7.396

7.  Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.

Authors:  Taro Yamashita; Anuradha Budhu; Marshonna Forgues; Xin Wei Wang
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

Review 8.  Cancer stem cells: impact, heterogeneity, and uncertainty.

Authors:  Jeffrey A Magee; Elena Piskounova; Sean J Morrison
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

9.  Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.

Authors:  Lu Cao; Yanming Zhou; Beibei Zhai; Jian Liao; Wen Xu; Ruixiu Zhang; Jing Li; Yu Zhang; Lei Chen; Haihua Qian; Mengchao Wu; Zhengfeng Yin
Journal:  BMC Gastroenterol       Date:  2011-06-14       Impact factor: 3.067

10.  CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells.

Authors:  Yi Chen; Dongke Yu; Hao Zhang; Hongwei He; Caixia Zhang; Wuli Zhao; Rong-Guang Shao
Journal:  Int J Biol Sci       Date:  2012-08-01       Impact factor: 6.580

View more
  7 in total

1.  MiR-15a suppresses hepatocarcinoma cell migration and invasion by directly targeting cMyb.

Authors:  Bo Liu; Ting Sun; Gang Wu; Hui Shang-Guan; Zhao-Jin Jiang; Ji-Ren Zhang; Yan-Fang Zheng
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

2.  Salivary gland cell aggregates are derived from self-organization of acinar lineage cells.

Authors:  Jomy J Varghese; M Eva Hansen; Azmeer Sharipol; Matthew H Ingalls; Martha A Ormanoski; Shawn D Newlands; Catherine E Ovitt; Danielle S W Benoit
Journal:  Arch Oral Biol       Date:  2018-10-22       Impact factor: 2.633

3.  Influence of TP53 and CDH1 genes in hepatocellular cancer spheroid formation and culture: a model system to understand cancer cell growth mechanics.

Authors:  Joseph M Pomo; Robert M Taylor; Rama R Gullapalli
Journal:  Cancer Cell Int       Date:  2016-06-13       Impact factor: 5.722

4.  Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA.

Authors:  Shuzhen Zhao; Xinlei Guan; Ruijie Hou; Xueying Zhang; Fang Guo; Zhifang Zhang; Caihong Hua
Journal:  Ann Transl Med       Date:  2020-09

5.  SNU-333 Cells as an Appropriate Cell Line for the Orthotopic Renal Cell Carcinoma Model.

Authors:  Inyoub Chang; Takbum Ohn; Daeun Moon; Young Hee Maeng; Bo Gun Jang; Sang-Pil Yoon
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

6.  The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPKα.

Authors:  Meng Zhang; Yuan Yuan; Qing Wang; Xiaobo Li; Jiuzhang Men; Mingxin Lin
Journal:  Biosci Rep       Date:  2018-11-07       Impact factor: 3.840

7.  Metastatic renal cell carcinoma cells growing in 3D on poly‑D‑lysine or laminin present a stem‑like phenotype and drug resistance.

Authors:  Klaudia K Brodaczewska; Zofia F Bielecka; Kamila Maliszewska-Olejniczak; Cezary Szczylik; Camillo Porta; Ewa Bartnik; Anna M Czarnecka
Journal:  Oncol Rep       Date:  2019-09-18       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.